Nasr ZG, Said H, Barakat K, Elwan R, Maklad S, Nazar ZJ. An Evaluation of Pre-Post Antimicrobial Stewardship Healthcare Intervention Studies Utilizing the Kirkpatrick Model: A Scoping Review. Int J Clin Pharm 2025. https://doi.org/10.1007/s11096-025-02007-w
Nasr ZG, Shehzad H, Wilby KJ. Pharmacists’ perceptions of the impact of Objective Structured Clinical Examination on professional development and competence: a cross-sectional study in Qatar. Int J Pharm Prac 2025;33(1):95-101. https://doi: 10.1093/ijpp/riae078
El Hajj MS, Saleh M, Ibrahim N, El Awaisi A, Stewart D, Baraka M, Nasr ZG. A cross-sectional study of vaccination-related education in pharmacy programs in the Middle East. Am J Pharm Educ. 2024;88(7):100715.
Nasr ZG, Elamin W, Basil M, Eljaaly K. Pharmacist-driven antimicrobial stewardship interventions in patients with COVID-19: A scoping review. Int J Clin Pharm. 2023;45(3):613-621.
Abushanab D, Nasr ZG, Al-Badriyeh D. Efficacy and safety of colistin versus tigecycline for multi-drug-resistant and extensively drug-resistant gram-negative pathogens-A meta-analysis. Antibiotics. 2022;11(11):1630.
Nasr ZG, Alhaj Moustafa D, Dahmani S, Wilby KJ. Investigating pharmacy students’ therapeutic decision-making with respect to antimicrobial stewardship cases. BMC Med Educ. 2022;17;22(1):467.
Paravattil B, Zolezzi M, Nasr ZG, Benkhadra M, AlAsmar M, Hussein S, Maklad A. An Interventional call-back service to improve appropriate
use of Antibiotics in community pharmacies. Antibiotics. 2021;10:986.
Nasr ZG, Abbara D, Wilby KJ. A scoping review of antimicrobial stewardship training in pharmacy education curricula. Am J Pharm Educ. 2021;85(6):8415.
Nasr ZG, Jibril F, ElMekaty E, Sonallah H, Chahine E, AlNajjar A. Assessment of antimicrobial stewardship programs within governmental hospitals in Qatar: A SWOC analysis. Int J Pharm Pract. 2021;29(1):70-77.
Thomas B, Abdulrouf P, ElKassem W, AlHail F, Nazar Z, Nasr ZG, Singh R, AlSoub H, Stewart D, AlHail M. Clinical and economic impact of antimicrobial stewardship interventions reported among hospital inpatients in the Middle East: A systematic review protocol. Research Square 2020.
Nasr ZG and Gauthier TP. Five things pharmacists should know about pre-exposure prophylaxis (PrEP) for HIV prevention. 2019. Available on https://www.idstewardship.com/five-things-pharmacists-know-preexposure-
prophylaxis-prep-hiv-prevention/
Nasr ZG, Higazy A, Wilbur K. Exploring the gaps between education and pharmacy practice on antimicrobial stewardship: A qualitative study among pharmacists in Qatar. Adv Med Educ Pract. 2019;10:287-295.
Nasr ZG, ElAzzazy S, Babiker A, ElBasheer M, Osman A, Wilby KJ. Practice implications of an antimicrobial stewardship intervention in a tertiary care teaching hospital in Qatar. East Mediterr Health J. 2019;25(3):1-9.
Diab M, Nasr ZG, ElHajj MS, Elewa H, Mohammed H, Wilby KJ Exploring the influence of language on assessment given a mismatch between language of instruction and language of practice. Sim Healthcare. 2019;14:271-275.
Nasr ZG, Abu Yousef S, Jibril F, Wilby KJ. Critical appraisal of febrile neutropenia guidelines in adult population with cancer. Int J Pharm Pract. 2018;26(1):49-54.
Nasr Z, Paravattil B, Wilby KJ. The impact of antimicrobial stewardship strategies on antibiotic appropriateness and prescribing behaviours in selected countries in the Middle East: a systematic review. East Mediterr Health J. 2017;23(6):430-440.
Nasr ZG and Wilby KJ. Introducing problem-based learning into a Canadian accredited Middle Eastern educational setting. Curr Pharm Teach Learn. 2017;9(4):719-722.
Nasr ZG, Jalali F, Ahmed D, Wilby KJ. Impact of sodium-glucose co transporter 2 inhibitors on cardiovascular outcomes in patients with type 2 diabetes mellitus: A systematic review. J Health Spec. 2017;5(1):16-22.
Nasr ZG and Saad MO. Short versus regular-course antimicrobial therapy for intraabdominal infections. Int J Pharm Pract. 2017;25(1):99.
Wilby KJ, Nasr ZG, Elazzazy S, Lau T, Hamad A. A Review of Clinical Outcomes Associated with Two Meropenem Dosing Strategies. Drugs in R&D. 2017;17(1):73-78.
Wilby KJ, Pawluk SA, Nasr ZG. An overview of pharmacokinetic considerations for the use of artemisinin-based combinations in three unique populations. Int J Pharmacokinet. 2017;2(1):71-78.
Wilby KJ and Nasr ZG. Bridging theory and practice: Mixed methods approach to instruction of law and ethics within the pharmaceutical sciences. Saudi Pharm J, 2016;24(6):669-673.
Wilby KJ and Nasr ZG. Zika Virus: Facts, prevention strategies, and an informed tourist perspective. Can J Hosp Pharm. 2016;69(3):255-256.
Nasr ZG, Paravattil B, Wilby KJ. Levetiracetam for seizure prevention in brain tumor patients: A systematic review. J Neurooncol. 2016;129(1):1-13.
Nasr ZG, Jalali F, Ahmed D, Wilby KJ. Impact of sodium-glucose co-transporter 2 inhibitors on cardiovascular outcomes in patients with type 2 diabetes mellitus: A systematic review (Abstract). Eur J Hosp Pharm. 2016; 23: Supplement 1.
Zeenny R, Nasr ZG, Adaimy I. Retrospective evaluation of the appropriate use of piperacillin/tazobactam in a tertiary care teaching hospital in Lebanon. Acta Medica Mediterranea. 2014;30(3):655-663.